$Palantir Technologies Inc.(PLTR)$
Palantir, as a data analytics and software company, isn't directly tied to geopolitical events like the Israel-Hamas conflict. However, the stock market is often influenced by a range of external factors, and geopolitical tensions can certainly play a role in investor sentiment. When there are uncertainties or conflicts in the world, investors sometimes seek safety in more stable assets or move their investments around accordingly.
As for the target price for PLTR, it's a challenging question. Predicting stock prices is notoriously difficult, and it involves a lot of variables, including the company's financial performance, market conditions, and investor sentiment. There are financial analysts and experts who make predictions, but even they can't provide a definite target price.
It's important to remember that investing in the stock market carries inherent risks, and the best approach is to do thorough research, consult with financial professionals, and diversify your investments to manage risk effectively. Additionally, keeping an eye on the news and geopolitical events, like the Israel-Hamas conflict, is crucial for understanding potential market fluctuations. But making investment decisions solely based on such events can be risky.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
If you think PLTR will beat the ER whisper numbers and reach $20+ on 2 Nov, please give me thumbs up.
Palantir co-founder Peter Thiel recently secured a 5-year service contract with the U.K.’s NHS to enhance data analysis using AI tools. Analysts have discussed the deal’s implications, providing some reasons to be bullish and reasons to be critical of the deal.
PLTR looks okay from books. But valuation is fairly high for no earning but at least they are moving in the right direction.
Charlie Munger rates PLTR as one of top 3 stocks to own!!
More will sell soon when hit that 15.50
Load up next week for earnings